跳至主要内容
临床试验/NCT00746044
NCT00746044已完成不适用

Evaluation of the Ratio of Urinary Coproporphyrins I and III as a Potential Biomarker of MRP2 Function in Man

University Hospital, Tours1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Urinary coproporphyrins (I/I+III)ratio

研究概览

简要总结

Human Multidrug Related Protein 2 (MRP2) excretes several drugs and could therefore modulate their elimination. Individual's MRP2 activity is under genetic control. Thus it would be very useful to get an easily measurable biomarker reflecting individual's MRP2 activity. We aimed to investigate the ratio of urinary coproporphyrins I and III (UCP(I/I+III), known to be increased in patients with mutations in MRP2/ABCC2 gene.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Affiliated to an health insurance

排除标准

  • Patient not able to understand or to comply to the protocol

结局指标

主要结局

Urinary coproporphyrins (I/I+III)ratio

时间窗: End of three 24-hours periods

次要结局

  • ABCC2 polymorphisms(At the time of entering in the study)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验